PMID- 37659438 OWN - NLM STAT- MEDLINE DCOM- 20231026 LR - 20240210 IS - 1873-7064 (Electronic) IS - 0028-3908 (Print) IS - 0028-3908 (Linking) VI - 240 DP - 2023 Dec 1 TI - A novel inhibitory corticostriatal circuit that expresses mu opioid receptor-mediated synaptic plasticity. PG - 109696 LID - S0028-3908(23)00286-1 [pii] LID - 10.1016/j.neuropharm.2023.109696 [doi] AB - Corticostriatal circuits are generally characterized by the release of glutamate neurotransmitter from cortical terminals within the striatum. It is well known that cortical excitatory input to the dorsal striatum regulates addictive drug-related behaviors. We previously reported that anterior insular cortex (AIC) synaptic inputs to the dorsolateral striatum (DLS) control binge alcohol drinking in mice. These AIC-DLS glutamate synapses are also the sole sites of corticostriatal mu opioid receptor-mediated excitatory long-term depression (MOR-LTD) in the DLS. Recent work demonstrates that some regions of cortex send long-range, direct inhibitory inputs into the dorsal striatum. Nothing is known about the existence and regulation of AIC-DLS inhibitory synaptic transmission. Here, using a combination of patch clamp electrophysiology and optogenetics, we characterized a novel AIC-DLS corticostriatal inhibitory circuit and its regulation by MOR-mediated inhibitory LTD (MOR-iLTD). First, we found that the activation of presynaptic MORs produces MOR-iLTD in the DLS and dorsomedial striatum. Then, we showed that medium spiny neurons within the DLS receive direct inhibitory synaptic input from the cortex, specifically from the motor cortex and AIC. Using transgenic mice that express cre-recombinase within parvalbumin-expressing inhibitory neurons, we determined that this specific cortical neuron subtype sends direct GABAergic projections to the DLS. Moreover, these AIC-DLS inhibitory synaptic input subtypes express MOR-iLTD. These data suggest a novel GABAergic corticostriatal circuit that could be involved in the regulation of drug and alcohol consumption-related behaviors. CI - Copyright (c) 2023 Elsevier Ltd. All rights reserved. FAU - Munoz, Braulio AU - Munoz B AD - Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. Electronic address: bmunozra@iupui.edu. FAU - Atwood, Brady K AU - Atwood BK AD - Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. LA - eng GR - R01 AA027214/AA/NIAAA NIH HHS/United States GR - UL1 TR002529/TR/NCATS NIH HHS/United States PT - Journal Article DEP - 20230901 PL - England TA - Neuropharmacology JT - Neuropharmacology JID - 0236217 RN - 0 (Receptors, Opioid, mu) RN - 0 (Glutamates) SB - IM MH - Mice MH - Animals MH - *Receptors, Opioid, mu/genetics/metabolism MH - *Neuronal Plasticity/physiology MH - Synaptic Transmission/physiology MH - Corpus Striatum/metabolism MH - Mice, Transgenic MH - Glutamates PMC - PMC10591984 MID - NIHMS1930424 OTO - NOTNLM OT - Anterior insular cortex OT - Dorsal striatum OT - GABA transmission OT - Long-term depression OT - Medium spiny neurons OT - Parvalbumin interneurons COIS- Declaration of competing interest The authors declare no conflict of interest. EDAT- 2023/09/03 00:41 MHDA- 2023/10/26 06:42 PMCR- 2024/12/01 CRDT- 2023/09/02 19:23 PHST- 2023/05/18 00:00 [received] PHST- 2023/08/28 00:00 [revised] PHST- 2023/08/30 00:00 [accepted] PHST- 2024/12/01 00:00 [pmc-release] PHST- 2023/10/26 06:42 [medline] PHST- 2023/09/03 00:41 [pubmed] PHST- 2023/09/02 19:23 [entrez] AID - S0028-3908(23)00286-1 [pii] AID - 10.1016/j.neuropharm.2023.109696 [doi] PST - ppublish SO - Neuropharmacology. 2023 Dec 1;240:109696. doi: 10.1016/j.neuropharm.2023.109696. Epub 2023 Sep 1.